Moran, A., Ramakrishnan, S., Borg, C., Connolly, C., Couillard, S., Mwasuku, C., . . . Lehtimaki, L. (2020). Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma. European Respiratory Society.
Chicago Style (17th ed.) CitationMoran, A., S. Ramakrishnan, C. Borg, C. Connolly, S. Couillard, C. Mwasuku, I. Pavord, T. Hinks, and L. Lehtimaki. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
MLA引文Moran, A., et al. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
警告:這些引文格式不一定是100%准確.